HUNTER TAUBMAN FISCHER & LI LLC

  • Nova York
  • Washington
  • Miami
Picture: Someone typing on a computer

A firma de advocacia Hunter Taubman Fischer & Li LLC

está empenhada em prover um serviço superior, respeitando os padrões éticos mais elevados.

Possuímos uma vasta base de conhecimento e ampla experiência, o que proporciona uma clara vantagem aos nossos clientes.

Nossa equipe está empenhada em alcançar excelência profissional e oferecer um serviço excepcional.

homepage_clients homepage_global homepage_growth

Nossa firma seleciona cuidadosamente seus advogados, entre os melhores profissionais do campo jurídico, e oferece serviços especificamente projetados para permitir que as empresas cresçam com sucesso e de modo consistente.

Nossa representação é focada principalmente em pequenas e médias empresas com o objetivo de aumentar a receita e manter o crescimento. Representamos clientes em uma variedade de indústrias, e em todos os estágios de desenvolvimento.

Desde as decisões de negócios rotineiras às transações comerciais mais complexas e globais, nossos clientes confiam na nossa firma para guiá-los através de suas necessidades legais.

Updates

News

Guidelines for Public Companies during the Federal Government Shutdown

2019-01-13

In light of the federal government shutdown commencing on December 22, 2018, the U.S. Securities and Exchange Commission (“SEC”) remains leanly staffed. This has caused delay in staff’s review of registration statements and other filings, and the SEC will not be able to declare any registration statements effective during the shutdown. Nevertheless, regardless of the SEC’s operational status, EDGAR will still accept filings.

Veja o artigo

News

First Nasdaq IPO of 2019: Boustead Client China SXT Pharma Up 43% in SXTC’s Debut After USD$10.2 Million Funding

2019-01-09

HTFL’s Client China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. 

Veja o artigo

Eventos

2019 SPAC Conference - Lou Taubman invited as a Moderator

2019-02-04

 

The SPAC Conference is the largest forum for networking and discussion of special purpose acquisition companies and alternative IPO techniques.

Veja o evento